Loading…
Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications
There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting...
Saved in:
Published in: | Small structures 2024-05, Vol.5 (5), p.n/a |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63 |
---|---|
cites | cdi_FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63 |
container_end_page | n/a |
container_issue | 5 |
container_start_page | |
container_title | Small structures |
container_volume | 5 |
creator | Yu, Yiyan Peng, Yifei Shen, Wei‐Ting Zhou, Zhidong Kai, Mingxuan Gao, Weiwei Zhang, Liangfang |
description | There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting hybrid cell membrane‐coated nanoparticles (hybrid CNPs) exhibit a higher level of synergy among multifunctionalities with better multitasking capabilities than their monotypic membrane‐coated counterparts. This advancement has catalyzed the initiation of numerous research opportunities, marking the advent of a promising frontier in therapeutic applications. This review outlines emerging biomedical applications of hybrid CNPs, focusing on drug targeting, immune modulation, biological neutralization, and disease diagnosis. Within each application, the review underscores how the strategic hybridization of distinct cell membranes augments the resulting nanoparticle therapeutic efficacy. Overall, the insights presented herein consolidate our understanding of current applications and may inspire novel designs with new biomedical applications.
This review summarizes recent advancements in developing hybrid cell membrane‐coated nanoparticles (hybrid CNPs), emphasizing their growing applications in drug targeting, immune modulation, biological neutralization, and disease diagnosis. The unique functions resulting from membrane hybridization in each hybrid CNP design are highlighted, and the future perspectives of hybrid CNPs are discussed. |
doi_str_mv | 10.1002/sstr.202300473 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2a5434fe130149c88f22ece5522038f2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2a5434fe130149c88f22ece5522038f2</doaj_id><sourcerecordid>3051765858</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63</originalsourceid><addsrcrecordid>eNqFUMtOwzAQjBBIVKVXzpE4p_gR2_GxRNBWKiDRcrZce4NSpXGwU6He-AS-kS8hJahw47Szq5nZ0UTRJUZjjBC5DqH1Y4IIRSgV9CQaEJ5lSYo4Of2Dz6NRCBvUCRjGQopBNJ3t1760cQ5VFd_Ddu11DZ_vH7nTLdj4Qdeu0b4tTQUhLpyPb0q3BVsaXcWTpqk60JauDhfRWaGrAKOfOYye725X-SxZPE7n-WSRmJRQmlDOMWAskcgECAlccks4BRCCAie80NZKLQoDhlJA0hrBDDeWasE4X3M6jOa9r3V6oxpfbrXfK6dL9X1w_kX9xFVEs5SmBWCKcCpNlhWEgAHGCEG0Wzqvq96r8e51B6FVG7fzdRdfUcSw4CxjWcca9yzjXQgeiuNXjNShe3XoXh277wSyF7yVFez_YavlcvX0q_0CxteH6Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3051765858</pqid></control><display><type>article</type><title>Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications</title><source>Wiley Open Access</source><creator>Yu, Yiyan ; Peng, Yifei ; Shen, Wei‐Ting ; Zhou, Zhidong ; Kai, Mingxuan ; Gao, Weiwei ; Zhang, Liangfang</creator><creatorcontrib>Yu, Yiyan ; Peng, Yifei ; Shen, Wei‐Ting ; Zhou, Zhidong ; Kai, Mingxuan ; Gao, Weiwei ; Zhang, Liangfang</creatorcontrib><description>There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting hybrid cell membrane‐coated nanoparticles (hybrid CNPs) exhibit a higher level of synergy among multifunctionalities with better multitasking capabilities than their monotypic membrane‐coated counterparts. This advancement has catalyzed the initiation of numerous research opportunities, marking the advent of a promising frontier in therapeutic applications. This review outlines emerging biomedical applications of hybrid CNPs, focusing on drug targeting, immune modulation, biological neutralization, and disease diagnosis. Within each application, the review underscores how the strategic hybridization of distinct cell membranes augments the resulting nanoparticle therapeutic efficacy. Overall, the insights presented herein consolidate our understanding of current applications and may inspire novel designs with new biomedical applications.
This review summarizes recent advancements in developing hybrid cell membrane‐coated nanoparticles (hybrid CNPs), emphasizing their growing applications in drug targeting, immune modulation, biological neutralization, and disease diagnosis. The unique functions resulting from membrane hybridization in each hybrid CNP design are highlighted, and the future perspectives of hybrid CNPs are discussed.</description><identifier>ISSN: 2688-4062</identifier><identifier>EISSN: 2688-4062</identifier><identifier>DOI: 10.1002/sstr.202300473</identifier><language>eng</language><publisher>Weinheim: John Wiley & Sons, Inc</publisher><subject>Biomedical materials ; cell membrane coatings ; Cell membranes ; hybrid membranes ; Mimicry ; Multitasking ; nanomedicines ; Nanoparticles ; nanotechnologies</subject><ispartof>Small structures, 2024-05, Vol.5 (5), p.n/a</ispartof><rights>2024 The Authors. Small Structures published by Wiley‐VCH GmbH</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63</citedby><cites>FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63</cites><orcidid>0000-0003-0637-0654</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fsstr.202300473$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fsstr.202300473$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,11542,27903,27904,46030,46454</link.rule.ids></links><search><creatorcontrib>Yu, Yiyan</creatorcontrib><creatorcontrib>Peng, Yifei</creatorcontrib><creatorcontrib>Shen, Wei‐Ting</creatorcontrib><creatorcontrib>Zhou, Zhidong</creatorcontrib><creatorcontrib>Kai, Mingxuan</creatorcontrib><creatorcontrib>Gao, Weiwei</creatorcontrib><creatorcontrib>Zhang, Liangfang</creatorcontrib><title>Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications</title><title>Small structures</title><description>There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting hybrid cell membrane‐coated nanoparticles (hybrid CNPs) exhibit a higher level of synergy among multifunctionalities with better multitasking capabilities than their monotypic membrane‐coated counterparts. This advancement has catalyzed the initiation of numerous research opportunities, marking the advent of a promising frontier in therapeutic applications. This review outlines emerging biomedical applications of hybrid CNPs, focusing on drug targeting, immune modulation, biological neutralization, and disease diagnosis. Within each application, the review underscores how the strategic hybridization of distinct cell membranes augments the resulting nanoparticle therapeutic efficacy. Overall, the insights presented herein consolidate our understanding of current applications and may inspire novel designs with new biomedical applications.
This review summarizes recent advancements in developing hybrid cell membrane‐coated nanoparticles (hybrid CNPs), emphasizing their growing applications in drug targeting, immune modulation, biological neutralization, and disease diagnosis. The unique functions resulting from membrane hybridization in each hybrid CNP design are highlighted, and the future perspectives of hybrid CNPs are discussed.</description><subject>Biomedical materials</subject><subject>cell membrane coatings</subject><subject>Cell membranes</subject><subject>hybrid membranes</subject><subject>Mimicry</subject><subject>Multitasking</subject><subject>nanomedicines</subject><subject>Nanoparticles</subject><subject>nanotechnologies</subject><issn>2688-4062</issn><issn>2688-4062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>DOA</sourceid><recordid>eNqFUMtOwzAQjBBIVKVXzpE4p_gR2_GxRNBWKiDRcrZce4NSpXGwU6He-AS-kS8hJahw47Szq5nZ0UTRJUZjjBC5DqH1Y4IIRSgV9CQaEJ5lSYo4Of2Dz6NRCBvUCRjGQopBNJ3t1760cQ5VFd_Ddu11DZ_vH7nTLdj4Qdeu0b4tTQUhLpyPb0q3BVsaXcWTpqk60JauDhfRWaGrAKOfOYye725X-SxZPE7n-WSRmJRQmlDOMWAskcgECAlccks4BRCCAie80NZKLQoDhlJA0hrBDDeWasE4X3M6jOa9r3V6oxpfbrXfK6dL9X1w_kX9xFVEs5SmBWCKcCpNlhWEgAHGCEG0Wzqvq96r8e51B6FVG7fzdRdfUcSw4CxjWcca9yzjXQgeiuNXjNShe3XoXh277wSyF7yVFez_YavlcvX0q_0CxteH6Q</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Yu, Yiyan</creator><creator>Peng, Yifei</creator><creator>Shen, Wei‐Ting</creator><creator>Zhou, Zhidong</creator><creator>Kai, Mingxuan</creator><creator>Gao, Weiwei</creator><creator>Zhang, Liangfang</creator><general>John Wiley & Sons, Inc</general><general>Wiley-VCH</general><scope>24P</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8FD</scope><scope>JG9</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0637-0654</orcidid></search><sort><creationdate>202405</creationdate><title>Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications</title><author>Yu, Yiyan ; Peng, Yifei ; Shen, Wei‐Ting ; Zhou, Zhidong ; Kai, Mingxuan ; Gao, Weiwei ; Zhang, Liangfang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomedical materials</topic><topic>cell membrane coatings</topic><topic>Cell membranes</topic><topic>hybrid membranes</topic><topic>Mimicry</topic><topic>Multitasking</topic><topic>nanomedicines</topic><topic>Nanoparticles</topic><topic>nanotechnologies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Yiyan</creatorcontrib><creatorcontrib>Peng, Yifei</creatorcontrib><creatorcontrib>Shen, Wei‐Ting</creatorcontrib><creatorcontrib>Zhou, Zhidong</creatorcontrib><creatorcontrib>Kai, Mingxuan</creatorcontrib><creatorcontrib>Gao, Weiwei</creatorcontrib><creatorcontrib>Zhang, Liangfang</creatorcontrib><collection>Wiley Open Access</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Small structures</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Yiyan</au><au>Peng, Yifei</au><au>Shen, Wei‐Ting</au><au>Zhou, Zhidong</au><au>Kai, Mingxuan</au><au>Gao, Weiwei</au><au>Zhang, Liangfang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications</atitle><jtitle>Small structures</jtitle><date>2024-05</date><risdate>2024</risdate><volume>5</volume><issue>5</issue><epage>n/a</epage><issn>2688-4062</issn><eissn>2688-4062</eissn><abstract>There is growing interest in developing cell membrane‐coated nanoparticles (CNPs) for unique host cell mimicry and therapeutic applications. The continuous evolution of this technology has motivated the coating of nanoparticles with hybrid membranes originating from diverse cell types. The resulting hybrid cell membrane‐coated nanoparticles (hybrid CNPs) exhibit a higher level of synergy among multifunctionalities with better multitasking capabilities than their monotypic membrane‐coated counterparts. This advancement has catalyzed the initiation of numerous research opportunities, marking the advent of a promising frontier in therapeutic applications. This review outlines emerging biomedical applications of hybrid CNPs, focusing on drug targeting, immune modulation, biological neutralization, and disease diagnosis. Within each application, the review underscores how the strategic hybridization of distinct cell membranes augments the resulting nanoparticle therapeutic efficacy. Overall, the insights presented herein consolidate our understanding of current applications and may inspire novel designs with new biomedical applications.
This review summarizes recent advancements in developing hybrid cell membrane‐coated nanoparticles (hybrid CNPs), emphasizing their growing applications in drug targeting, immune modulation, biological neutralization, and disease diagnosis. The unique functions resulting from membrane hybridization in each hybrid CNP design are highlighted, and the future perspectives of hybrid CNPs are discussed.</abstract><cop>Weinheim</cop><pub>John Wiley & Sons, Inc</pub><doi>10.1002/sstr.202300473</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-0637-0654</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2688-4062 |
ispartof | Small structures, 2024-05, Vol.5 (5), p.n/a |
issn | 2688-4062 2688-4062 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_2a5434fe130149c88f22ece5522038f2 |
source | Wiley Open Access |
subjects | Biomedical materials cell membrane coatings Cell membranes hybrid membranes Mimicry Multitasking nanomedicines Nanoparticles nanotechnologies |
title | Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A45%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hybrid%20Cell%20Membrane%E2%80%90Coated%20Nanoparticles%20for%20Biomedical%20Applications&rft.jtitle=Small%20structures&rft.au=Yu,%20Yiyan&rft.date=2024-05&rft.volume=5&rft.issue=5&rft.epage=n/a&rft.issn=2688-4062&rft.eissn=2688-4062&rft_id=info:doi/10.1002/sstr.202300473&rft_dat=%3Cproquest_doaj_%3E3051765858%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4233-3661e1190787e79e696d263ee773e626fadd9a7fcec33e09dc75c6cd3a7566b63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3051765858&rft_id=info:pmid/&rfr_iscdi=true |